LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Test Rapidly Diagnoses Sepsis

By LabMedica International staff writers
Posted on 01 Jun 2017
Image: The TaqMan Multiplex Master Mix for real-time polymerase chain reactions (Photo courtesy of Thermo Fisher Scientific).
Image: The TaqMan Multiplex Master Mix for real-time polymerase chain reactions (Photo courtesy of Thermo Fisher Scientific).
Rapid diagnosis of sepsis in hospitalized patients is crucial because in severe cases, there is an average 7.6% decrease in survival rate per hour from the onset of low blood pressure without effective antimicrobial treatment.

Early identification of a pathogen increases the chance of targeting the correct agent and may avoid misuse of antibiotics. A molecular test has been developed that can rapidly and reliably diagnose sepsis, a potentially life-threatening complication of bacterial infections.

Scientists at the Tongde Hospital of Zhejiang Province designed primers and TaqMan probes that were to be complementary to conserved regions in the 16S rDNA gene of different kinds of bacteria. To evaluate accurately, sensitively, and specifically, the known bacteria samples (Standard strains, whole blood samples) are determined by TaqMan-Based Multiplex real-time polymerase chain reaction (PCR). In addition, 30 blood samples taken from patients with clinical symptoms of sepsis were tested by TaqMan-Based Multiplex real-time PCR and blood culture.

The investigators found that the mean frequency of positive for Multiplex real-time PCR was 96% at a concentration of 100 colony-forming units (CFU)/mL, and it was 100% at a concentration greater than 1,000 CFU/mL. All the known blood samples and standard strains were detected positively by TaqMan-Based Multiplex PCR; no PCR products were detected when DNAs from other bacterium were used in the multiplex assay. Among the 30 patients with clinical symptoms of sepsis, 18 patients were confirmed positive by Multiplex real-time PCR and seven patients were confirmed positive by blood culture.

The authors concluded that TaqMan-Based Multiplex real-time PCR assay with highly sensitivity, specificity and broad detection range was a rapid and accurate method in the detection of bacterial pathogens of sepsis and should have a promising usage in the diagnosis of sepsis. The study was published on May 17, 2017, in the Journal of Clinical Laboratory Analysis.

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more